Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,404 | -5,276 | -1,811 | N/A | N/A |
| Depreciation Amortization | 162 | 46 | 4 | N/A | N/A |
| Accounts receivable | 8 | -7 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -6 | 286 | 445 | N/A | N/A |
| Other Working Capital | 10,046 | -70 | 470 | N/A | N/A |
| Other Operating Activity | 9,546 | 2,846 | -375 | 0 | 0 |
| Operating Cash Flow | $-5,648 | $-2,175 | $-1,267 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -943 | -91 | -3 | N/A | N/A |
| Investing Cash Flow | $-943 | $-91 | $-3 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 1,500 | 500 | N/A | N/A |
| Common Stock Issued | 117,077 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 48,365 | 980 | 0 | 0 | 0 |
| Financing Cash Flow | $165,442 | $2,480 | $500 | $N/A | $N/A |
| Exchange Rate Effect | -11 | -7 | 9 | N/A | N/A |
| Beginning Cash Position | 564 | 357 | 1,118 | N/A | N/A |
| End Cash Position | 159,404 | 564 | 357 | N/A | N/A |
| Net Cash Flow | $158,840 | $207 | $-761 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,648 | -2,175 | -1,267 | N/A | N/A |
| Capital Expenditure | -943 | -91 | -3 | N/A | N/A |
| Free Cash Flow | -6,591 | -2,266 | -1,270 | 0 | 0 |